Novartis Returns US Rights to Advair, Easing Glaxo Threat - BusinessWeek

Novartis Returns US Rights to Advair, Easing Glaxo Threat
BusinessWeek
March 18 (Bloomberg) -- Novartis AG returned US development rights to a generic version of an asthma drug to UK partner Vectura Group Plc, ...

and more »

continue reading

Annoying allergies back in season; experts offer tips to those who suffer - Herald & Review

Annoying allergies back in season; experts offer tips to those who suffer
Herald & Review
"You can develop an allergy to pollen at any time potentially, just like you could a drug, some other agent," Beede said, adding that allergic rhinitis ...

and more »

continue reading

E-prescriptions cut medication errors: study - Reuters

E-prescriptions cut medication errors: study
Reuters
The systems also typically provide doctors with a drug's allergy warnings, potential for interacting with other medications and other information that could ...

and more »

continue reading

Dr Reddy's gets USFDA nod for Allegra generic - Moneycontrol.com

Dr Reddy's gets USFDA nod for Allegra generic
Moneycontrol.com
Dr Reddy's Laboratories has received the US Food and Drug Administration's approval to launch the generic version of Sanofi-Aventis' allergy drug Allegra, ...
Dr Reddy's gets FDA nod for Allegra genericInteractive Investor

all 2 news articles »

continue reading

It's Going to be a Longer Allergy Season: Arm Yourself with the Irrigator - PR NewsChannel (press release)

continue reading